Inflammatory bowel disease in relation to contact allergy: A patient-based study

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 5, 2007, Pages 572-576

  Engkilde, Kåre ^a,b   Menné, Torkil ^a   Johansen, Jeanne Duus ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b National Allergy Research Centre   (Denmark)

Author keywords

Allergic contact dermatitis; Contact allergy; Crohn disease; Patch tests; Ulcerative colitis

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALLERGY TEST; ARTICLE; CHILD; COHORT ANALYSIS; CONTACT ALLERGY; CROHN DISEASE; DELAYED HYPERSENSITIVITY; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATCH TEST; PRIORITY JOURNAL; REFERENCE DATABASE; SAMPLE SIZE; SEX RATIO; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; DENMARK; DERMATITIS, ALLERGIC CONTACT; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, CELLULAR; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; ODDS RATIO; PATCH TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; T-LYMPHOCYTES;

EID: 34247362417     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600999334     Document Type: Article

References (44)

1. Moed H, Stoof TJ, Boorsma DM, von Blomberg BM, Gibbs S, Bruynzeel DP, et al. Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 T cell profiles. Clin Exp Allergy 2004;34:1868-75.
2. Kitagaki H, Ono N, Hayakawa K, Kitazawa T, Watanabe K, Shiohara T. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J Immunol 1997; 159:2484-91.
3. Kitagaki H, Kimishima M, Teraki Y, Hayakawa J, Hayakawa K, Fujisawa S, et al. Distinct in vivo and in vitro cytokine profiles of draining lymph node cells in acute and chronic phases of contact hypersensitivity: importance of a type 2 cytokine-rich cutaneous milieu for the development of an early-type response in the chronic phase. J Immunol 1999;163:1265-73.
4. Vocanson M, Hennino A, Chavagnac C, Saint-Mezard P, Dubois B, Kaiserlian D, et al. Contribution of CD4+/ and CD8+/ T-cells in contact hypersensitivity and allergic contact dermatitis. Expert Rev Clin Immunol 2005;1:75-86.
5. Nieuwenhuis EE, Gillessen S, Scheper RJ, Exley MA, Taniguchi M, Balk SP, et al. CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity. Exp Dermatol 2005;14:250-8.
6. Mortz CG, Lauritsen JM, Bindslev-Jensen C, Andersen KE. Contact allergy and allergic contact dermatitis in adolescents: prevalence measures and associations. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis (TOACS). Acta Derm Venereol 2002;82:352-8.
7. Nielsen NH, Linneberg A, Menne T, Madsen F, Frolund L, Dirksen A, et al. Allergic contact sensitization in an adult Danish population: two cross-sectional surveys eight years apart (Copenhagen Allergy Study). Acta Derm Venereol 2001;81:31-4.
8. Agner T, Menné T. Individual predisposition to irritant and allergic contact dermatitis. In: Frosch PJ, Menné T, Lepoittevin J-P, editors. Contact dermatitis, 4th ed. Berlin Heidelberg: Springer; 2006. pp 127-34.
9. Bryld LE, Hindsberger C, Kyvik KO, Agner T, Menne T. Genetic factors in nickel allergy evaluated in a population-based female twin sample. J Invest Dermatol 2004;123:1025-9.
10. Karvonen J, Silvennoinen-Kassinen S, Ilonen J, Jakkula H, Tiilikainen A. HLA antigens in nickel allergy. Ann Clin Res 1984;16:211-2.
11. Westphal GA, Schnuch A, Moessner R, Konig IR, Kranke B, Hallier E, et al. Cytokine gene polymorphisms in allergic contact dermatitis. Contact Dermatitis 2003;48:93-8.
12. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29.
13. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la MC, Strong SA, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996;157:1261-70.
14. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002;20:495-549.
15. Brant SR, Shugart YY. Inflammatory bowel disease gene hunting by linkage analysis: rationale, methodology, and present status of the field. Inflamm Bowel Dis 2004;10:300-11.
16. Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003;124:1767-73.
17. Jess T, Riis L, Jespersgaard C, Hougs L, Andersen PS, Orholm MK, et al. Disease concordance, zygosity, and NOD2/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease. Am J Gastroenterol 2005;100:2486-2492.
18. Wilkinson DS, Fregert S, Magnusson B, Bandmann HJ, Calnan CD, Cronin E, et al. Terminology of contact dermatitis. Acta Derm Venereol 1970;50:287-92.
19. Wahlberg JE, Lindberg M. Patch testing. In: Frosch PJ, Menné T, Lepoittevin J-P, editors. Contact dermatitis, 4th ed. Berlin Heidelberg: Springer; 2006. pp 365-90.
20. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-8.
21. Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a six-fold increase in incidence. Scand J Gastroenterol 1992;27:609-14.
22. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-17.
23. Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 1991;26:1247-56.
24. Fonager K, Sorensen HT, Olsen J. Change in incidence of Crohn's disease and ulcerative colitis in Denmark. A study based on the National Registry of Patients, 1981-1992. Int J Epidemiol 1997;26:1003-8.
25. Fonager K, Sorensen HT, Rasmussen SN, Moller-Petersen J, Vyberg M. Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system. Scand J Gastroenterol 1996;31:154-9.
26. Uter W, Pfahlberg A, Gefeller O, Geier J, Schnuch A. Risk factors for contact allergy to nickel: results of a multifactorial analysis. Contact Dermatitis 2003;48:33-8.
27. Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev 2004;3:394-400.
28. Linneberg A, Nielsen NH, Menne T, Madsen F, Jorgensen T. Smoking might be a risk factor for contact allergy. J Allergy Clin Immunol 2003;111:980-4.
29. Cumberbatch M, Kimber I. Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 1995;84:31-5.
30. Shibata M, Sueki H, Suzuki H, Watanabe H, Ohtaki H, Shioda S, et al. Impaired contact hypersensitivity reaction and reduced production of vascular endothelial growth factor in tumor necrosis factor-alpha gene-deficient mice. J Dermatol 2005;32:523-33.
31. Dahlin J, Sorensen SF. Experiences with infliximab in the treatment of active rheumatoid arthritis and spondyloarthropathy. Ugeskr Laeger 2003;165:4646-9.
32. Pugh SM, Rhodes J, Mayberry JF, Roberts DL, Heatley RV, Newcombe RG. Atopic disease in ulcerative colitis and Crohn's disease. Clin Allergy 1979;9:221-3.
33. Myrelid P, Dufmats M, Lilja I, Grinn C, Lannerstad O, Sjodahl R. Atopic manifestations are more common in patients with Crohn disease than in the general population. Scand J Gastroenterol 2004;39:731-6.
34. Niwa Y, Sumi H, Akamatsu H. An association between ulcerative colitis and atopic dermatitis, diseases of impaired superficial barriers. J Invest Dermatol 2004;123:999-1000.
35. Troncone R, Merrett TG, Ferguson A. Prevalence of atopy is unrelated to presence of inflammatory bowel disease. Clin Allergy 1988;18:111-7.
36. Triantafillidis JK, Economidou J, Manousos ON, Efthymiou P. Cutaneous delayed hypersensitivity in Crohn's disease and ulcerative colitis. Application of multi-test. Dis Colon Rectum 1987;30:536-9.
37. D'Arienzo A, Manguso F, Scarpa R, Astarita C, D'Armiento FP, Bennato R, et al. Ulcerative colitis, seronegative spondyloarthropathies and allergic diseases: the search for a link. Scand J Gastroenterol 2002;37:1156-63.
38. Fuss IJ, Heller F, Boirivant M, Leon F, Yoshida M, Fichtner-Feigl S, et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 2004;113:1490-7.
39. Saubermann LJ, Beck P, De Jong YP, Pitman RS, Ryan MS, Kim HS, et al. Activation of natural killer T cells by alphagalactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 2000;119:119-28.
40. Ueno Y, Tanaka S, Sumii M, Miyake S, Tazuma S, Taniguchi M, et al. Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of valpha14 natural killer T cells in mice. Inflamm Bowel Dis 2005;11:35-41.
41. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol 2001;100:144-8.
42. Berzins SP, Smyth MJ, Godfrey DI. Working with NKT cells: pitfalls and practicalities. Curr Opin Immunol 2005;17:448-54.
43. Campos RA, Szczepanik M, Itakura A, kahira-Azuma M, Sidobre S, Kronenberg M, et al. Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J Exp Med 2003;198:1785-96.
44. Engkilde K, Menné T, Johansen JD. Inverse relationship between allergic contact dermatitis and type 1 diabetes mellitus: a retrospective clinic-based study. Diabetologia 2006;49:644-7.